Unicycive Therapeutics (UNCY) Short Interest Ratio & Short Volume $0.55 -0.02 (-3.67%) Closing price 04:00 PM EasternExtended Trading$0.57 +0.02 (+3.81%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Unicycive Therapeutics Short Interest DataUnicycive Therapeutics (UNCY) has a short interest of 793,000 shares, representing 0.79% of the float (the number of shares available for trading by the public). This marks a -23.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 958,655 shares to cover all short positions.Current Short Interest793,000 sharesPrevious Short Interest1,040,000 sharesChange Vs. Previous Month-23.75%Dollar Volume Sold Short$516,718.80Short Interest Ratio0.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares120,629,000 sharesFloat Size100,030,000 sharesShort Percent of Float0.79%Today's Trading Volume1,108,289 sharesAverage Trading Volume958,655 sharesToday's Volume Vs. Average116% Short Selling Unicycive Therapeutics? Sign up to receive the latest short interest report for Unicycive Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUNCY Short Interest Over TimeUNCY Days to Cover Over TimeUNCY Percentage of Float Shorted Over Time Unicycive Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025793,000 shares $516,718.80 -23.8%0.8%0.9 $0.65 4/15/20251,040,000 shares $617,344.00 -39.2%1.1%1.1 $0.59 3/31/20251,710,000 shares $983,079.00 +12.5%1.7%1.6 $0.57 3/15/20251,520,000 shares $889,200.00 +8.6%1.8%1.5 $0.59 2/28/20251,400,000 shares $770,420.00 +76.1%1.6%1.3 $0.55 2/15/2025795,200 shares $470,837.92 -3.4%0.9%0.7 $0.59 1/31/2025823,300 shares $505,341.54 -51.6%0.9%0.6 $0.61 1/15/20251,700,000 shares $1.14 million +37.1%1.9%1.1 $0.67 12/31/20241,240,000 shares $984,808.00 +25.4%1.4%0.8 $0.79 12/15/2024989,200 shares $706,783.40 +18.2%1.1%0.7 $0.71 Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024837,200 shares $576,747.08 -33.6%1.0%0.5 $0.69 11/15/20241,260,000 shares $579,600.00 +20.0%1.5%0.8 $0.46 10/31/20241,050,000 shares $561,750.00 No Change1.2%0.5 $0.54 10/15/20241,050,000 shares $420,000.00 +5.7%1.2%0.5 $0.40 9/30/2024993,800 shares $405,371.02 +158.2%1.2%0.4 $0.41 9/15/2024384,900 shares $152,035.50 -48.5%0.5%0.1 $0.40 8/31/2024746,800 shares $252,269.04 -59.4%0.9%0.3 $0.34 8/15/20241,840,000 shares $552,000.00 +37.3%2.2%0.9 $0.30 7/31/20241,340,000 shares $585,714.00 -31.3%2.1%1 $0.44 7/15/20241,950,000 shares $973,050.00 +32.7%3.1%2 $0.50 6/30/20241,470,000 shares $736,617.00 +22.5%5.3%2 $0.50 6/15/20241,200,000 shares $778,680.00 +14.3%4.3%2.3 $0.65 5/31/20241,050,000 shares $924,000.00 +22.1%3.4%2.6 $0.88 5/15/2024859,800 shares $928,584.00 +49.5%3.2%2.3 $1.08 4/30/2024575,000 shares $644,000.00 +50.2%2.1%1.4 $1.12 4/15/2024382,900 shares $436,506.00 +49.1%1.5%1 $1.14 3/31/2024256,800 shares $354,384.00 +352.9%1.0%0.7 $1.38 3/15/202456,700 shares $82,782.00 +62.0%0.2%0.2 $1.46 2/29/202435,000 shares $48,300.00 -64.3%0.1%0.1 $1.38 2/15/202498,000 shares $128,380.00 +46.7%0.4%0.4 $1.31 1/31/202466,800 shares $63,460.00 -2.8%0.3%0.3 $0.95 1/15/202468,700 shares $57,708.00 -20.9%0.3%0.4 $0.84 12/31/202386,900 shares $75,403.13 +1.5%N/A0 $0.87 12/15/202385,600 shares $48,988.88 +65.6%0.3%0.9 $0.57 11/30/202351,700 shares $26,496.25 -30.0%0.2%0.7 $0.51 11/15/202373,900 shares $38,620.14 +18.6%0.3%1.4 $0.52 10/31/202362,300 shares $35,529.69 -42.7%0.3%1.2 $0.57 10/15/2023108,800 shares $93,350.40 -25.4%0.4%1.9 $0.86 9/30/2023145,800 shares $125,388.00 +34.5%0.6%2.4 $0.86 9/15/2023108,400 shares $75,045.32 +71.3%0.4%1.1 $0.69Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 8/31/202363,300 shares $48,291.57 -21.0%0.5%0.6 $0.76 8/15/202380,100 shares $60,876.00 -53.9%0.6%0.6 $0.76 7/31/2023173,800 shares $203,346.00 -16.0%3.2%1.1 $1.17 7/15/2023206,900 shares $254,487.00 -15.8%3.8%1 $1.23 6/30/2023245,800 shares $314,624.00 -10.3%2.7%1 $1.28 6/15/2023274,100 shares $433,078.00 +8.8%3.0%0.9 $1.58 5/31/2023252,000 shares $332,640.00 -13.6%2.7%0.1 $1.32 5/15/2023291,800 shares $417,274.00 +21.7%3.2%0.1 $1.43 4/30/2023239,700 shares $311,610.00 -8.0%2.6%0 $1.30 4/15/2023260,400 shares $460,908.00 -34.7%2.9%0 $1.77 3/31/2023398,700 shares $837,270.00 -71.3%4.4%0.1 $2.10 3/15/20231,390,000 shares $3.07 million +839.2%15.3%0.2 $2.21 2/28/2023148,000 shares $76,516.00 -17.9%1.6%0 $0.52 2/15/2023180,300 shares $100,968.00 +55.3%2.0%0.6 $0.56 1/31/2023116,100 shares $65,016.00 -40.6%1.3%0.4 $0.56 1/15/2023195,600 shares $97,311.00 -24.5%2.2%0.8 $0.50 12/30/2022259,000 shares $139,860.00 +284.3%2.9%1.1 $0.54 12/15/202267,400 shares $47,510.26 +18.5%0.7%2 $0.70 11/30/202256,900 shares $40,524.18 +4.8%0.6%2 $0.71 11/15/202254,300 shares $38,010.00 +35.8%0.6%2 $0.70 10/31/202240,000 shares $27,600.00 -7.4%0.4%1.6 $0.69 10/15/202243,200 shares $24,619.68 +7.2%0.5%1.3 $0.57 9/30/202240,300 shares $23,777.00 +53.2%0.4%1.2 $0.59 9/15/202226,300 shares $19,988.00 -36.0%0.3%0.8 $0.76 8/31/202241,100 shares $28,770.00 +21.2%0.5%1.2 $0.70 8/15/202233,900 shares $23,736.78 -62.1%0.4%0.9 $0.70 7/31/202289,500 shares $66,230.00 +54.6%1.0%2.4 $0.74 7/15/202257,900 shares $46,348.95 -29.6%0.6%1.9 $0.80 6/30/202282,200 shares $68,226.00 -12.7%0.9%2.5 $0.83 6/15/202294,200 shares $97,026.00 +17.3%1.0%2.5 $1.03 5/31/202280,300 shares $71,467.00 +49.0%0.9%1.3 $0.89 5/15/202253,900 shares $37,730.00 -39.4%0.6%0.7 $0.70 4/30/202288,900 shares $77,405.23 +1.5%1.0%1.1 $0.87 4/15/202287,600 shares $94,608.00 -35.1%1.0%0.7 $1.08 3/31/2022134,900 shares $174,021.00 +185.8%1.5%0.9 $1.29 3/15/202247,200 shares $50,504.00 -49.3%0.5%0.3 $1.07 2/28/202293,100 shares $129,409.00 -22.2%1.0%0.6 $1.39 2/15/2022119,600 shares $160,264.00 +51.8%1.3%0.7 $1.34 1/31/202278,800 shares $108,744.00 -49.9%0.9%0.4 $1.38 1/15/2022157,300 shares $281,567.00 +112.6%1.7%1 $1.79 12/31/202174,000 shares $152,440.00 +74.5%0.8%0.5 $2.06 12/15/202142,400 shares $95,824.00 -35.0%0.5%0.3 $2.26 11/30/202165,200 shares $139,528.00 -7.8%0.7%0.4 $2.14 11/15/202170,700 shares $188,062.00 -34.9%0.8%0.4 $2.66 10/29/2021108,600 shares $313,854.00 +1.5%1.3%0.6 $2.89 10/15/2021107,000 shares $291,040.00 +14.2%1.3%0.3 $2.72 9/30/202193,700 shares $265,171.00 +564.5%1.1%0.1 $2.83 9/15/202114,100 shares $41,031.00 -78.3%0.2%0 $2.91 8/31/202165,100 shares $188,790.00 +25.9%0.8%0 $2.90 8/13/202151,700 shares $141,141.00 No Change0.6%0 $2.73The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a UNCY Short Interest - Frequently Asked Questions What is Unicycive Therapeutics' current short interest? Short interest is the volume of Unicycive Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 793,000 shares of UNCY short. 0.79% of Unicycive Therapeutics' shares are currently sold short. Learn More on Unicycive Therapeutics' current short interest. What is a good short interest ratio for Unicycive Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UNCY shares currently have a short interest ratio of 1.0. Learn More on Unicycive Therapeutics's short interest ratio. What is a good short interest percentage for Unicycive Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.79% of Unicycive Therapeutics' floating shares are currently sold short. Is Unicycive Therapeutics' short interest increasing or decreasing? Unicycive Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 793,000 shares, a decline of 23.8% from the previous total of 1,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Unicycive Therapeutics' float size? Unicycive Therapeutics currently has issued a total of 120,629,000 shares. Some of Unicycive Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unicycive Therapeutics currently has a public float of 100,030,000 shares. How does Unicycive Therapeutics' short interest compare to its competitors? 0.79% of Unicycive Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Unicycive Therapeutics: Cartesian Therapeutics, Inc. (30.19%), Aura Biosciences, Inc. (4.83%), Canopy Growth Co. (10.08%), 2seventy bio, Inc. (5.37%), iTeos Therapeutics, Inc. (7.64%), Terns Pharmaceuticals, Inc. (8.30%), Monte Rosa Therapeutics, Inc. (17.13%), Lifecore Biomedical, Inc. (7.84%), Allogene Therapeutics, Inc. (13.77%), Atea Pharmaceuticals, Inc. (4.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Unicycive Therapeutics stock? Short selling UNCY is an investing strategy that aims to generate trading profit from Unicycive Therapeutics as its price is falling. UNCY shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unicycive Therapeutics? A short squeeze for Unicycive Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UNCY, which in turn drives the price of the stock up even further. How often is Unicycive Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UNCY, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Cartesian Therapeutics Short Interest Aura Biosciences Short Interest Canopy Growth Short Interest 2seventy bio Short Interest iTeos Therapeutics Short Interest Terns Pharmaceuticals Short Interest Monte Rosa Therapeutics Short Interest Lifecore Biomedical Short Interest Allogene Therapeutics Short Interest Atea Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UNCY) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UNCY Stock Free UNCY Stock Alerts